Citations

Showing 10 of 108119 citations.

First-in-Human Experience and Acute Procedural Outcomes Using a Novel Pulsed Field Ablation System: The PULSED AF Pilot Trial
Boersma, Lucas V.A. , Haines, David E., Natale, Andrea , Marchlinski, Francis E. , Sanders, Prashanthan , Calkins, Hugh , Packer, Douglas L. , Hummel, John D. , Önal, Birce , Rosen, Sofi, Kuck, Karl-Heinz , Hindricks, Gerhard, Wilsmore, Bradley , Verma, Atul , Boersma, Lucas , Natale, Andrea , Marchlinski, Francis E , Sanders, Prashanthan , Calkins, Hugh , Packer, Douglas L , Hummel, John , Onal, Birce , Kuck, Karl-Heinz , Wilsmore, Bradley , Haines, David E., Rosen, Sofi, Hindricks, Gerhard

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | December 29, 2021 | Volume: 15 | Issue: 1 | Pages: No page available

10.1161/circep.121.010168 | PMID 34964367 Get It

Background: Pulsed field ablation (PFA) is a novel form of ablation using electrical fields to ablate cardiac tissue. There are only limited data assessing the feasibility and safety of this type of ablation in humans. Methods: PULSED AF (Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF; https://www.clinicaltrials.gov ; unique identifier: NCT04198701) is a nonrandomized, prospective, multicenter, global, premarket clinical study. The first-in-human pilot phase evaluated the feasibility and efficacy of pulmonary vein isolation using a novel PFA system delivering bipolar, biphasic electrical fields through a circular multielectrode array catheter (PulseSelect; Medtronic, Inc). Thirty-eight patients with paroxysmal or persistent atrial fibrillation were treated in 6 centers in Australia, Canada, the United States, and the Netherlands. The primary outcomes were ability to achieve acute pulmonary vein isolation intraprocedurally and safety at 30 days. Results: Acute electrical isolation was achieved in 100% of pulmonary veins (n=152) in the 38 patients. Skin-to-skin procedure time was 160±91 minutes, left atrial dwell time was 82±35 minutes, and fluoroscopy time was 28±9 minutes. No serious adverse events related to the PFA system occurred in the 30-day follow-up including phrenic nerve injury, esophageal injury, stroke, or death. Conclusions: In this first-in-human clinical study, 100% pulmonary vein isolation was achieved using only PFA with no PFA system–related serious adverse events. Graphic Abstract: A graphic abstract is available for this article.
Editorial Commentary
Thompson, R. Houston, Findlay, Bridget L.

Mayo Clinic

Urology Practice | December 29, 2021 | Volume: 9 | Issue: 2 | Pages: 187-187

10.1097/upj.0000000000000292.01 | PMID 37145708 Get It

Invasive Right Ventricular Pressure-Volume Analysis: Basic Principles, Clinical Applications, and Practical Recommendations
Brener, Michael I. , Masoumi, Amirali, Ng, Vivian G., Tello, Khodr , Bastos, Marcelo B. , Cornwell, William K. , Hsu, Steven , Tedford, Ryan J. , Lurz, Philipp , Rommel, Karl-Philipp , Kresoja, Karl-Patrik , Nagueh, Sherif F. , Kanwar, Manreet , Kapur, Navin K. , Hiremath, Gurumurthy , Sarraf, Mohammad, Enden, Antoon J.M. Van Den, Heerdt, Paul M., Kodali, Susheel K., Uriel, Nir , Kanwar, Manreet K , Van Mieghem, Nicolas M , Hahn, Rebecca T , Sayer, Gabriel T , Uriel, Nir , Burkhoff, Daniel , Lurz, Philipp , Tedford, Ryan J , Brener, Michael I. , Masoumi, Amirali, Ng, Vivian G., Tello, Khodr , Bastos, Marcelo B. , Cornwell, William K. , Hsu, Steven , Rommel, Karl-Philipp , Kresoja, Karl-Patrik , Nagueh, Sherif F. , Kapur, Navin K , Hiremath, Gurumurthy , Sarraf, Mohammad, Enden, Antoon J.M. Van Den, Heerdt, Paul M., Kodali, Susheel K.

Mayo Clinic

Circulation: Heart Failure | December 29, 2021 | Volume: 15 | Issue: 1 | Pages: No page available

10.1161/circheartfailure.121.009101 | PMID 34963308 Get It

Right ventricular pressure-volume (PV) analysis characterizes ventricular systolic and diastolic properties independent of loading conditions like volume status and afterload. While long-considered the gold-standard method for quantifying myocardial chamber performance, it was traditionally only performed in highly specialized research settings. With recent advances in catheter technology and more sophisticated approaches to analyze PV data, it is now more commonly used in a variety of clinical and research settings. Herein, we review the basic techniques for PV loop measurement, analysis, and interpretation with the aim of providing readers with a deeper understanding of the strengths and limitations of PV analysis. In the second half of the review, we detail key scenarios in which right ventricular PV analysis has influenced our understanding of clinically relevant topics and where the technique can be applied to resolve additional areas of uncertainty. All told, PV analysis has an important role in advancing our understanding of right ventricular physiology and its contribution to cardiovascular function in health and disease.
Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis
Pose, Elisa , Solà, Elsa , Lozano, Juan José , Juanola, Adrià , Zaccherini, Giacomo , Wit, Koos de , Tonon, Marta , Kazankov, Konstantin , Jiménez, César , Campion, Daniela , Napoleone, Laura , T., Ann , Carol, Marta, Alessandria, Carlo , Beuers, Ulrich , Caraceni, Paolo , Trebicka, Jonel , Vargas, Vı́ctor , Abraldeṣ, Juan G. , Kamath, Patrick S. , Davis, Mark M. , Cervera, Marta , Solé, Cristina , Graupera, Isabel , Serra‐Burriel, Miquel , Gratacós‐Ginès, Jordi , Bassegoda, Octavi , Roux, Olivier , de Wit, Koos , Trebicka, Jonel , Piano, Salvatore , Gines, Pere , Ma, Ann T , Vargas, Victor , Jiménez, César , Abraldes, Juan G , Sidorova, Julia , Uschner, Frank Erhard , Morales‐Ruiz, Manuel , Francoz, Claire , Durand, François , Mookerjee, Rajeshwar P. , Piano, Salvatore , Watson, Hugh R , Ginès, Pere

Mayo Clinic

Hepatology Communications | December 29, 2021 | Volume: 6 | Issue: 5 | Pages: 1100-1112

10.1002/hep4.1881 | PMID 34964311 Get It

Patients with decompensated cirrhosis, particularly those with acute‐on‐chronic liver failure (ACLF), show profound alterations in plasma metabolomics. The aim of this study was to investigate the effect of treatment with simvastatin and rifaximin on plasma metabolites of patients with decompensated cirrhosis, specifically on compounds characteristic of the ACLF plasma metabolomic profile. Two cohorts of patients were investigated. The first was a descriptive cohort of patients with decompensated cirrhosis (n = 42), with and without ACLF. The second was an intervention cohort from the LIVERHOPE‐SAFETY randomized, double‐blind, placebo‐controlled trial treated with simvastatin 20 mg/day plus rifaximin 1,200 mg/day (n = 12) or matching placebo (n = 13) for 3 months. Plasma samples were analyzed using ultrahigh performance liquid chromatography–tandem mass spectroscopy for plasma metabolomics characterization. ACLF was characterized by intense proteolysis and lipid alterations, specifically in pathways associated with inflammation and mitochondrial dysfunction, such as the tryptophan–kynurenine and carnitine beta‐oxidation pathways. An ACLF‐specific signature was identified. Treatment with simvastatin and rifaximin was associated with changes in 161 of 985 metabolites in comparison to treatment with placebo. A remarkable reduction in levels of metabolites from the tryptophan–kynurenine and carnitine pathways was found. Notably, 18 of the 32 metabolites of the ACLF signature were affected by the treatment. Conclusion: Treatment with simvastatin and rifaximin modulates some of the pathways that appear to be key in ACLF development. This study unveils some of the mechanisms involved in the effects of treatment with simvastatin and rifaximin in decompensated cirrhosis and sets the stage for the use of metabolomics to investigate new targeted therapies in cirrhosis to prevent ACLF development.
Variability in endoscopic assessment of Nissen fundoplication wrap integrity and hiatus herniation
Song, Erin J. , Yadlapati, Rena , Chen, Joan W. , Parish, Alice , Whitson, Matthew J. , Ravi, Karthik , Patel, Amit , Carlson, Dustin A. , Khan, Abraham, Niedzwiecki, Donna , Leiman, David A. , Patel, A , Niedzwiecki, Donna , Ravi, Karthik , Khan, Abraham

Mayo Clinic

Diseases of the Esophagus | December 29, 2021 | Volume: 35 | Issue: 5 | Pages: No page available

10.1093/dote/doab078 | PMID 34963133 Get It

Summary Background Upper endoscopy (EGD) is frequently performed in patients with esophageal complaints following anti-reflux surgery such as fundoplication. Endoscopic evaluation of fundoplication wrap integrity can be challenging. Our primary aim in this pilot study was to evaluate the accuracy and confidence of assessing Nissen fundoplication integrity and hiatus herniation among gastroenterology (GI) fellows, subspecialists, and foregut surgeons. Methods Five variations of post-Nissen fundoplication anatomy were included in a survey of 20 sets of EGD images that was completed by GI fellows, general GI attendings, esophagologists, and foregut surgeons. Accuracy, diagnostic confidence, and inter-rater agreement across providers were evaluated. Results There were 31 respondents in the final cohort. Confidence in pre-survey diagnostics significantly differed by provider type (mean confidence out of 5 was 1.8 for GI fellows, 2.7 for general GI attendings, 3.6 for esophagologists, and 3.6 for foregut surgeons, P = 0.01). The mean overall accuracy was 45.9%, which significantly differed by provider type with the lowest rate among GI fellows (37%) and highest among esophagologists (53%; P = 0.01). The accuracy was highest among esophagologists across all wrap integrity variations. Inter-rater agreement was low across wrap integrity variations (Krippendorf’s alpha <0.30), indicating low to no agreement between providers. Conclusion In this multi-center survey study, GI fellows had the lowest accuracy and confidence in assessing EGD images after Nissen fundoplication, whereas esophagologists had the highest. Diagnostic confidence varied considerably and inter-rater agreement was poor. These findings suggest experience may improve confidence, but highlight the need to improve the evaluation of fundoplication wraps.
Long-term natural history and patterns of sporadic vestibular schwannoma growth: A multi-institutional volumetric analysis of 952 patients
Marinelli, John P. , Schnurman, Zane , Killeen, Daniel E. , Nassiri, Ashley M. , Lees, Katherine A. , Lohse, Christine M. , Golfinos, John G. , Link, Michael J. , Carlson, Matthew L. , Hunter, Jacob B. , Roland, J. Thomas , Kondziolka, Douglas

Mayo Clinic

Neuro-Oncology | December 28, 2021 | Volume: 24 | Issue: 8 | Pages: 1298-1306

10.1093/neuonc/noab303 | PMID 34964894 Get It

Abstract Background The current study aims to characterize the natural history of sporadic vestibular schwannoma volumetric tumor growth, including long-term growth patterns following initial detection of growth. Methods Volumetric tumor measurements from 3505 serial MRI studies were analyzed from unselected consecutive patients undergoing wait-and-scan management at three tertiary referral centers between 1998 and 2018. Volumetric tumor growth was defined as a change in volume ≥20%. Results Among 952 patients undergoing observation, 622 experienced tumor growth with initial growth-free survival rates (95% CI) at 1, 3, and 5 years following diagnosis of 66% (63–69), 30% (27–34), and 20% (17–24). Among 405 patients who continued to be observed despite demonstrating initial growth, 210 experienced subsequent tumor growth with subsequent growth-free survival rates at 1, 3, and 5 years following initial growth of 77% (72–81), 37% (31–43), and 24% (18–31). Larger tumor volume at initial growth (HR 1.13, P = .02) and increasing tumor growth rate (HR 1.31; P < .001) were significantly associated with an increased likelihood of subsequent growth, whereas a longer duration of time between diagnosis and detection of initial growth was protective (HR 0.69; P < .001). Conclusions While most vestibular schwannomas exhibit an overall propensity for volumetric growth following diagnosis, prior tumor growth does not perfectly predict future growth. Tumors can subsequently grow faster, slower, or demonstrate quiescence and stability. Larger tumor size and increasing tumor growth rate portend a higher likelihood of continued growth. These findings can inform timing of intervention: whether upfront at initial diagnosis, after detection of initial growth, or only after continued growth is observed.
Time in therapeutic range of anticoagulation among patients with atrial fibrillation and cerebral amyloid angiopathy
Graff‐Radford, Jonathan , Ponamgi, Shiva , English, Stephen , Meskill, Alayna, Challa, Apurva B., Hodge, David O. , Slusser, Joshua P. , Asirvatham, Samuel J. , Holmes, David R. , Ward, Robert C. , Asirvatham, Samuel J , Rabinstein, Alejandro A. , DeSimone, Christopher V.

Mayo Clinic

Baylor University Medical Center Proceedings | December 28, 2021 | Volume: 35 | Issue: 2 | Pages: 162-167

10.1080/08998280.2021.2013393 | PMID 35261442 Get It

Ultrasound Diagnosis of a Pseudotumor Secondary to a Partial Thickness Distal Biceps Tear Resulting in Pronator Syndrome: A Case Report
Boettcher, Brennan J. , Jelsing, Elena J., Camp, Christopher L.

Mayo Clinic

Clinical Journal of Sport Medicine | December 28, 2021 | Volume: 32 | Issue: 5 | Pages: e546-e549

10.1097/jsm.0000000000001003 | PMID 36083338 Get It

Abstract: A 53-year-old right-handed female weightlifter presented to our clinic for evaluation of left elbow pain and intermittent numbness in her first 3 digits. She reported an elbow injury while weight lifting and carrying heavy planters 6 months earlier. A magnetic resonance imaging obtained previously was interpreted as bicipital-radial bursitis, and she had previously undergone a comprehensive nonoperative management program for her pain and numbness. A diagnostic ultrasound performed in clinic revealed distal biceps tendinopathy, bicipital-radial bursitis, and “pseudotumor,” which was dynamically compressed between the biceps tendon and radius with pronation and also caused a mass effect on the median nerve at the level of the pronator teres. Surgical excision of the mass resulted in near-complete resolution of her symptoms, and histology was consistent with scar tissue. This is the first case to the best of our knowledge to describe point-of-care ultrasound diagnosis of a biceps tendon “pseudotumor,” as well as demonstrating dynamic impingement of this pseudotumor causing mass effect on the median nerve.
The Need for “Big Bioethics” Research
Pacyna, Joel E. , Sharp, Richard R. , Sharp, Richard R

Mayo Clinic

The American Journal of Bioethics | December 28, 2021 | Volume: 22 | Issue: 1 | Pages: 3-5

10.1080/15265161.2022.2009701 | PMID 34962190 Get It